Skip to main content

Endotoxin adsorption method may affect serum procalcitonin

Introduction

When septic patients progress to endotoxin shock, they present a high mortality rate. The mortality rate of septic patients with multiple organ failure has been reported to be 30–80%. The endotoxin adsorption method (PMX-DHP: Toray Industries, Inc., Tokyo, Japan) has been used for treatment of patients with severe sepsis and septic shock primarily caused by Gram-negative infections in Japan. We also reported that PMX-DHP removed plasma endotoxin and improved hemodynamic parameters in clinical trials [1]. The purpose of this study was to assess the changes of procalcitonin (PCT) values during PMX-DHP.

Methods

The retrospective study was carried out in our ICU. In this study, 68 septic patients who had multiple organ failure due to intra-abdominal infection were treated with PMX-DHP. Sepsis was diagnosed according to the criteria of the ACCP/SCCM Consensus Conference Committee. These patients were separated into two groups: those who survived for at least 28 days after the start of PMX-DHP therapy (S group; 49 patients), and those who did not (nonsurvival group; 19 patients). Background factors and inflammatory mediators were examined in each group. PCT was measured by immunoluminometric assay before and after PMX-DHP and 24 hours later. The luminometer used was an Autolumat LB953 (Berthord, Bad Wildbad, Germany). Endotoxin (kinetic turbidimetric method) was also measured just before and immediately after PMX-DHP.

Results

The 28-day survival rate was 72.1% (49 survivors, 19 nonsurvivors). The APACHE II scores were 22.0 ± 8.3 and 28.3 ± 7.0 and the Sequential Organ Failure Assessment scores were 9.1 ± 3.9 and 11.1 ± 2.8 in the survival and nonsurvival groups, respectively, showing significantly higher scores in the nonsurvival group. PCT before PMX-DHP in all patients was 59.1 ± 97.2 ng/ml and tended to decrease 54.7 ± 81.7 ng/ml after PMX-DHP. PCT was 59.4 ± 109.4 ng/ml before PMX-DHP and significantly decreased to 42.2 ± 67.4 ng/ml at 24 hours after PMX-DHP in the survival group, but it did not change significantly in the nonsurvival group. There was a significant correlation between endotoxin and PCT (r = 0.527, P < 0.001).

Conclusion

Our results may suggest that PMX-DHP can reduce systemic inflammatory cytokines and serum PCT in the survival group.

References

  1. 1.

    Ikeda T, et al.: Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial 2004, 8: 293-298. 10.1111/j.1526-0968.2004.00167.x

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ikeda, T., Ikeda, K., Ueno, T. et al. Endotoxin adsorption method may affect serum procalcitonin. Crit Care 12, P186 (2008). https://doi.org/10.1186/cc6407

Download citation

Keywords

  • Septic Patient
  • Sequential Organ Failure Assessment
  • Multiple Organ Failure
  • Survival Group
  • Procalcitonin